Cheyne-Stokes respiration classification

Cheyne-Stokes respiration Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cheyne-Stokes respiration from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cheyne-Stokes respiration classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cheyne-Stokes respiration classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cheyne-Stokes respiration classification

CDC on Cheyne-Stokes respiration classification

Cheyne-Stokes respiration classification in the news

Blogs on Cheyne-Stokes respiration classification

Directions to Hospitals Treating Cheyne-Stokes respiration

Risk calculators and risk factors for Cheyne-Stokes respiration classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Overview[edit | edit source]

## Epidemiology and Demographics[edit | edit source]

### Association with Congestive Heart Failure (CHF)[edit | edit source]

Although the incidence of CSR is unknown, it seems to be fairly common in patients with New York Heart Association (NYHA) class III and IV disease.

* One study found that 45% of patients with moderate, stable, optimally treated CHF had CSR with an apnea – hypopnea index (AHI) >20\. These episodes were associated with a SaO2 < 90% for ¼ - ½ of total sleep time. The patients were also found to have a significant increase in the number of episodes of nocturnal ventricular arrhythmias.
* Another study found that although the cardiac parameters did not differ between patients, those with CHF and CSR has reduced total sleep time, reduced sleep efficiency, increased proportion of stages I, II, and NREM sleep and reduced REM sleep. By definition, they had higher AHIs, however the degree of hypoxemia during desaturation did not differ between the groups.
* The recurrent desaturations and arousals experienced by patients with CHF and CSR have been associated with an increase in nocturnal angina and ventricular arrhythmias. It has also been shown that these patients have higher circulating plasma norepinephrine levels, which can obviously worsen afterload and heart failure.

### Association with Stroke[edit | edit source]

CSR was once thought only to occur with bilateral or large deeper strokes, however is now recognized to be much more common, and can be seen in patients with ischemic stroke in any location.

* One study identified CSR in 59% of patients with supratentorial stroke, and in 40% with infratentorial stroke. The patients with CSR had a significant decrease in SaO2 as compared to those without CSR, and the authors raised the concern for potential worsening of ischemia in the peri-infarct zone, due to low sats in these patients.

## References[edit | edit source]

Template:WH Template:WS